 OncLive | The Therapeutic Landscape of Metastatic Renal Cell Carcinoma in 2012 OncLive The mTOR inhibitors temsirolimus and everolimus are sirolimus analogues, which inhibit mTOR by binding to FkBP-12. While assumed to have similar mechanistic actions, the two drugs have been studied in very different patient populations (Table 1). |
